HighTower Advisors »

Fennec Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $140k 15k 9.36
2025-06-30 $125k 15k 8.30

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
Solas Capital Management
Rosalind Advisors
BlackRock
Vanguard Group
AIGH Capital Management
State Street Corporation
Tang Capital Management
Geode Capital Management
Morgan Stanley
Harbert Fund Advisors
Jeffrey L. Gendell
Northern Trust
Lion Point Capital
Citadel Advisors

View all funds holding Fennec Pharmaceuticals